free concentration - Physiologie et Thérapeutique Ecole Véto

advertisement

PK/PD approach for antibiotics: tissue or blood drug levels to predict antibiotic efficacy

PL Toutain

National Veterinary school; Toulouse

Wuhan 8 October 2015

Objectives of the presentation:

1.

The three PK/PD indices

2.

Where are located the bugs ?

Extracellular vs. intracellular

3.

Where is the biophase?

• Interstitial space fluid vs. intracellular cytosol vs. intracellular organelles

4.

How to assess the biophase antibiotic concentration

• Total tissular concentration vs. ISF concentration.

5.

The issue of lung penetration

1.

Epithelial lining fluid (ELF):?

2.

he hypothesis of targeted delivery of the active drug at the infection site by phagocytes

6.

Plasma as the best surrogate of biophase concentration for PK/PD interpretation

First (scientific) consensus:

The goal of PK/PD indices

1. The goal of PK/PD indices is to predict, in vivo, clinical outcomes:

• Cure

• prevention of resistance

2. Plasma free concentration is the relevant concentration for the establishment of a PKPD indice

Statements such as ‘concentrations in tissue x h after dosing are much higher than the MICs for common pathogens that cause disease’ are meaningless

Mouton & al JAC 2007

For pulmonary infection, plasma free antibiotic concentration, not the epithelial

Lining Fluid (ELF), is the best surrogate of biophase concentration

Second (marketing) consensus

• It is more easy to promote a macrolide showing its high lung concentrations than its low plasma concentrations

MIC distribution for M haemolytica & P multocida (2004-20010) for tulathromycin

The PK/PD issue for macrolides

(triamilides): plasma concentration lower than MICs

MIC

• Good clinical efficacy and bacteriological cure with macrolides is achievable with plasma concentrations

(much) lower, than the in vitro

MICs for major lung pathogens

Cmax =0.5µg/mL ≤ to MIC

90

MIC in MHB vs. calf serum

25%,50%,75% and 100%

MIC in MHB

MIC in serum

25% 50% 75%

100 %

9

The case of tulathromycin

• See presentation entitled “ how to establish a dosage regimen for a sustainable use of antibiotics

10

1: Where are located the pathogens and where is the biophase

Where are located the pathogens

ISF

Most pathogens of clinical interest

• S. Pneumoniae, E. Coli,Klebsiella

Cell

( most often in phagocytic cell)

• Mannhemia ; Pasteurella

Actinobacillius pleuropneumoniae

• Mycoplasma hyopneumoniae

• Mycoplasma (some)

• Chlamydiae

• Brucella

• Cryptosporidiosis

• Listeria monocytogene

• Salmonella

• Mycobacteria

• Rhodococcus equi

• Bordetalla bronchiseptia

2: What are Antibiotic concentrations that are considered in the veterinary literature to explain antibiotic efficacy?

Antibiotic concentrations vs. efficacy

1. Total tissue concentrations

– homogenates

– biopsies

2. Extracellular fluids concentrations

– implanted cages

– implanted threads

– wound fluid

– blister fluid

– ISF (Microdialysis, Ultrafiltration)

Leipzig 2009 17

3: why a total tissular concentration has no meaning

Leipzig 2009 19

The inadequate tissue penetration hypothesis: Schentag 1990

• Two false assumptions

1. tissue is homogenous

2. bacteria are evenly distributed through tissue

 spurious interpretation of all important tissue/serum ratios in predicting the antibacterial effect of

AB

Schentag, 1990

Total tissular concentration for betalactams and aminoglycosides

• if a compound is distributed mainly extra-cellularly (betalactams and aminoglycosides), a total tissular concentration will underestimate the active concentration at the biophase by diluting the ISF with intracellular fluids .

Intracellular location of antibiotics

Cytosol pH=7.4

Fluoroquinolones(x2-8) beta-lactams (x0.2-0.6)

Rifampicin (x2)

Aminoglycosides (slow

Phagolysosome volume 1 to 5% of cell volume pH=5.0

Macrolides (x10-50)

Aminoglycosides (x2-4)

Ion trapping for weak base with high pKa value

Leipzig 2009 22

Total tissular concentration for macrolides & quinolones

• if a drug is accumulated in cells (the case for fluoroquinolones and macrolides), assays of total tissue levels will lead to gross overestimation of the extracellular biophase concentration.

4: what are the methods for studies of target site drug distribution in antimicrobial chemotherapy

PET images following administration of

18 f-trovafloxacine

Muller & al AAC 2004

Prague 2008 25

Methods considered of limited interest for studies of target site drug distribution

• Tools developed to determine antibiotic concentrations in various surrogates for the ISF and having no pathophysiologic counterpart in humans .

– in vitro models,

– fibrin clots,

– tissue chambers ,

– skin chambers(blister)

– wound exudates,

– surface fluids,

– implanted fibrin clots,

– peripheral lymph.

Muller & al AAC 2004

The tissue cage model for in vivo and ex vivo investigations

The tissue cage model

• Perforated hollow devices

• Subcutaneous implantation

• development of a highly vascularized tissue

• fill up with a fluid with half protein content of serum

(delay 8 weeks)

•C.R. Clarke. J. Vet. Pharmacol. Ther. 1989, 12: 349-368

Leipzig 2009 28

PK in tissue cage in situ administration

• PK determined by the cage geometry (SA/V ratio is the major determinant of peak and trough drug level)

• T1/2 varies with the surface area / volume ratio of the tissue cage

– Penicillin 5 to 20 h

– Danofloxacin 3 to 30 h

Greko, 2003, PhD Thesis

The Tissue cage model: veterinary application

• To describe PK at site of infection (calves, dogs, horses…): NO

• To assess the influence pf inflammation by comparing exudate and transudate concentration

• To investigate PK/PD relationship: YES

– ex vivo : killing curves (exudate/transudate)

– in vivo : Greko (inoculation of the tissue cage)

5-Microdialysis & ultrafiltration

Techniques

What is microdialysis (MD)?

• Microdialysis, a tool to monitors free antibiotic concentrations in the fluid which directly surrounds the infective agent

Microdialysis: The Principle

• The MD Probe mimics a "blood capillary ".

•There is an exchange of substances via extracellular fluid

•Diffusion of drugs is across a semipermeable membrane at the tip of an MD probe implanted into the ISF of the tissue of interest.

Microdialysis : Limits

• MD need to be calibrated

• Retrodialysis method

– tedious.

– The in vivo percent recovery is calculated

(CV of about 10-20%)

MD need to be calibrated:

A small experimental error in recovery estimate results in a relatively larger error in drug concentration estimates which is probably responsible for the greater interanimal variability observed in lung tissue than in the other media

Marchand & al AAC June 2005

Ultrafiltration

• Excessive ( in vivo ) calibration procedures are required for accurate monitoring

• Unlike MD, UFsample concentrations are independent on probe diffusion characteristics

Microdialysis vs. Ultrafiltration

Ultrafiltration

Vacuum

Microdialysis : a fluid is pumped through a membrane;

The driving force is a pressure differential (a vacuum) applied across the semipermeable membrane

The analyte cross the membrane by diffusion

The driving force is a concentration gradient

Marbofloxacin : plasma vs.ISF

In vivo filtration

Microdialysis

•Not suitable for long term in vivo studies

Ultrafiltration

•Suitable for long term sampling (in larger animals, the UF permits complete freedom of movement by using vacutainer collection method)

Bidgood & Papich JVPT 2005 28 329

42

This study’s objectives were to determine intestinal antimicrobial concentrations in calves administered enrofloxacin or ceftiofur sodium subcutaneously, and their impact on representative enteric bacteria

Ultrafiltration devices were implanted in the ileum and colon of 12 steers,

43

Enrofloxacin (SQ, 7.5mg/kg)

AUC (enro+cipro)

• Plasma=19 (total)

• ISF=25 (free)

• Ileaum=21 (free)

• Spiral colon =36 (free)

44

Ceftiofur SQ (2.2mg/kg)

AUC

• Plasma=137 (total)

• ISF=15 (free)

• Ileum=40 (free)

• Spiral Colon =34 free)

6-What we learnt with animal and human microdialysis studies

Plasma (total, free) concentration vs interstitial concentration (muscle, adipose tissue) (Moxifloxacin)

Total (plasma, muscle) free (plasma) interstitial muscle interstitial adipose tissue

1000

100

Muller AAC, 1999

2 6 10 12

Time (h)

20 30 40

Plasma (total, free) concentration vs muscle (free) concentration cefpodoxine

Total (plasma) free (muscle) free (plasma) cefixime

Liu J.A.C. 2002

What we learnt with animal and human MD studies

• MD studies showed that :

– the concentrations in ISF of selected antibiotics correspond to unbound concentrations in plasma and are much lower than concentrations reported from wholetissue biopsy specimens.

– Concentrations of beta –lactams and aminoglycosides in

ISF are mostly in the range of free concentrations in serum

– Concentration of quinolones and macrolides at their target site are considerably lower than those predicted from tissue biopsy specimens

What we learnt with animal and human microdialysis studies

• Free plasma concentration is a good surrogate of most interstial fluid (ISF) concentration

MIC measured in MHB is homogeneous to a “free concentration”

Effect of protein binding on antimicrobial activity

6

MICs of Staphylococcus aureus (Data from Kunin et al 1973 )

5

4

3

2

1

0 f b

Ampi Methy Benz NAF Oxa Cloxa

0.22 0.37

0.65

0.90

0.93

0.95

MIC Broth

MIC Serum

Cf for MIC Serum

The free concentration paradigm in pharmacokinetics is supported by MD findings

Blood/Plasma Interstitial fluid Tissular space

Total

Measured by analytical technique

Plasma bound

Free

ISF bound

BUG

Tissue bound

Free Free

Elimination

What we learnt with MD studies:

Inflammation

Tissue concentrations of levofloxacin in inflamed and healthy subcutaneous adipose tissue

Hypothesis : Accumulation of fibrin and other proteins, oedema, changed pH and altered capillary permeability may result in local penetration barriers for drugs

Inflammation

No inflammation

Methods : Free Concentrations measured by microdialysis after administration of a single intravenous dose of 500 mg.

Bellmann & al Br J Clin Pharmacol 2004 57

Results: The penetration of levofloxacin into tissue appears to be unaffected by local inflammation.

Same results obtained with others quinolones

What we learnt with MD studies:

Inflammation

• Acute inflammatory events seem to have little influence on tissue penetration.

• “ These observations are in clear contrast to reports on the increase in the target site availability of antibiotics by macrophage drug uptake and the preferential release of antibiotics at the target site a concept which is also used as a marketing strategy by the drug industry ” Muller

& al AAC May 2004

7-The issue of lung penetration

Animal and human studies MD:

The issue of lung penetration

•Lung MD require maintenance under anesthesia, thoracotomy (patient undergoing lung surgery)..

•Does the unbound concentrations in muscle that are relatively accessible constitute reasonable predictors of the unbound concentrations in lung tissue (and other tissues)?

Cefpodoxime at steady state: plasma vs. ISF (muscle & Lung)

Plasma

Free plasma

Muscle Lung

Free muscle concentrations of cepodoxime were similar to free lung concentration and therefore provided a surrogate measure of cefpodoxime concentraion at the pulmonary target site

Liu et al., JAC, 2002 50 Suppl: 19-22.

Possible confounding factors in interpreting ELF concentrations of antibiotics measured by BAL

• ELF: Epithelial lining Fluid

• BAL:bronchoalveolar lavage

•Fenestrated pulmonary capillary bed

• expected to permit passive diffusion of antibiotics with a molecular weight 1,000

The blood-alveolar barrier

Epithelial lining fluid

ELF

The alveolar epithelial cells would not be expected to permit passive diffusion of antibiotics between cells, the cells being linked by tight junctions

Kiem & Schentag’ Conclusions (1)

• The high ELF concentrations of some antibiotics, which were measured by the BAL technique, might be explained by possible contamination from high achieved intracellular concentrations and subsequent lysis of these cells during the measurement of ELF content .

• This effect is similar to the problem of measuring tissue content using homogenization

Kiem & Schentag’ Conclusions (2)

• Fundamentally, ELF may not represent the lung site where antibiotics act against infection .

• In view of the technical and interpretive problems with conventional ELF and especially BAL, the lung microdialysis experiments may offer an overall better correlation with microbiological outcomes .

• .

8-The site of infection:

Intracellular pathogens

PK/PD indices and tissular concentrations

• Currently, no equivalent recommendation has been published with tissular concentration as PK input and that, for any tissue or any type of infection including intracellular infection.

Key questions for intracellular antibiotherapy

• Where are the bacteria ?

• Which antibiotics accumulate in cells ?

• Where are antibiotics located ?

• What is the intracellular expression of activity ?

• What is the bacterial responsiveness ?

• Cooperation with the cell own defenses and cytokines ?

Tulkens - Bangalore

Intracellular location of bacteria

B

Fusion

Lysosome

1

3

B pH=7.4

Phagosome

B

2

4

B

Chlamydiae

B

Listeria

No fusion with lysosome

Cytosol

Phagolysosome

B

B

S.aureaus

Brucella

B

Salmonella

Coxiella burneti pH=5.0

Intracellular location of antibiotics

Cytosol pH=7.4

Fluoroquinolones(x2-8) beta-lactams (x0.2-0.6)

Rifampicin (x2)

Aminoglycosides (slow

Phagolysosome volume 1 to 5% of cell volume pH=5.0

Macrolides (x10-50)

Aminoglycosides (x2-4)

Ion trapping for weak base with high pKa value

Leipzig 2009 68

Which antibiotics do accumulate in cells ?

• beta-lactams :

1 x

• aminoglycosides: <1 to 2 x

• ansamycins:

• tetracyclines:

2-3 x

2-4 x

• fluoroquinolones: 10-20 x

• macrolides: 4 to > 100 x

What are the antibiotic intracellular activity

Cytosol pH=7.2

Fluoroquinolones beta-lactams

Rifampicin

Aminoglycosides

Good

Phagolysosome

Macrolides

Aminoglycosides

Low or nul

Leipzig 2009 71

Conclusions

PK/PD indices and tissular concentrations

• Currently, no recommendation has been published with tissular concentration as PK input and that, for any tissue or any type of infection including intracellular infection.

The free plasma level is the most meaningful concentration

In acute infections in nonspecialized tissues, where there is no abscess formation,

free plasma

levels of antibiotics are good predictors of free levels in interstitial fluid

Some statements on total tissular concentrations

• For veterinary medicine (Apley, 1999)

– people who truly understand tissue concentration work in corporate marketing departments

• For human medicine (Kneer, 1993)

– tissular concentrations are inherently inaccurate

– tissular concentrations studies little contribute to the understanding of in vivo efficacy and optimal dosing

Never use tissue concentrations to determine an antibiotic dose

According to EMEA

"unreliable information is generated from assays of drug concentrations in whole tissues

(e.g. homogenates)"

EMEA 2000

Download